phenylalanine has been researched along with Adverse Drug Event in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lah, M; McPheron, M | 1 |
| Bielefeldt, K; Gawron, AJ | 1 |
| Donnenfeld, ED; Hovanesian, JA; Karpecki, PM; Nichols, KK; Raychaudhuri, A; Shojaei, A; Zhang, S | 1 |
| Al-Kali, A; Cherry, M; Ghabache, B; Khawandanah, M; Ozer, H; Selby, G; Srour, S; Zhao, ZJ | 1 |
| Arnold, GL; Cohen-Pfeffer, JL; Enns, GM; Ficicioglu, C; Longo, N; Parker, S; Pridjian, G | 1 |
| Hussar, DA | 1 |
| Barbellion, S; Bergmann, B; Brunel, P; Clark, RL; Crofts, F; DeLise, B; Guittin, P; Hofmann, T; Lerman, S; Pino, M; Potdevin, S | 1 |
| Barbellion, S; Brunel, P; Clark, R; Crofts, F; DeLise, B; Guittin, P; Hofmann, T; Lerman, S; Lockey, P; Nguyen, M; Pino, M; Rohatagi, S; Schmidt, J; Wong, M; Zhang, J | 1 |
| Hirose, T; Kawamori, R; Kawasumi, M; Kurebayashi, S; Tanaka, Y; Watada, H | 1 |
| Chail, M; Dhaneshwar, SS; Naqvi, S; Patil, M; Vadnerkar, G | 1 |
3 trial(s) available for phenylalanine and Adverse Drug Event
| Article | Year |
|---|---|
Safety and tolerability of lifitegrast ophthalmic solution 5.0%: Pooled analysis of five randomized controlled trials in dry eye disease.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Dry Eye Syndromes; Female; Humans; Male; Middle Aged; Ophthalmic Solutions; Phenylalanine; Prospective Studies; Sulfones; Treatment Outcome; Visual Analog Scale | 2019 |
Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera.
Topics: Adult; Aged; Amino Acid Substitution; Antineoplastic Agents; Drug-Related Side Effects and Adverse Reactions; Erlotinib Hydrochloride; Female; Humans; Janus Kinase 2; Male; Middle Aged; Phenylalanine; Polycythemia Vera; Quinazolines; Treatment Outcome; Valine | 2015 |
Efficacy and adverse effects of nateglinide in early type 2 diabetes. Comparison with voglibose in a cross-over study.
Topics: Aged; alpha-Glucosidases; Appetite; Body Weight; Cross-Over Studies; Cyclohexanes; Diabetes Mellitus, Type 2; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Gastrointestinal Tract; Glycated Hemoglobin; Humans; Hypoglycemia; Inositol; Lipids; Liver Function Tests; Male; Middle Aged; Nateglinide; Phenylalanine; Treatment Outcome | 2006 |
7 other study(ies) available for phenylalanine and Adverse Drug Event
| Article | Year |
|---|---|
Palynziq clinic: One year and 43 patients later.
Topics: Adolescent; Adult; Ambulatory Care Facilities; Anaphylaxis; Consensus; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Phenylalanine; Phenylalanine Ammonia-Lyase; Phenylketonurias; Recombinant Proteins; Young Adult | 2021 |
Risk of Pancreatitis Following Treatment of Irritable Bowel Syndrome With Eluxadoline.
Topics: Adult; Aged; Aged, 80 and over; Drug-Related Side Effects and Adverse Reactions; Female; Gastrointestinal Agents; Humans; Imidazoles; Incidence; Irritable Bowel Syndrome; Male; Middle Aged; Pancreatitis; Phenylalanine; Product Surveillance, Postmarketing; Risk Assessment | 2018 |
Long-term safety and efficacy of sapropterin: the PKUDOS registry experience.
Topics: Adolescent; Adult; Biopterins; Child; Child, Preschool; Diet; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Phenylalanine; Phenylketonurias; Registries; Time Factors; Tyrosine; Young Adult | 2015 |
New drugs 2002, part 1.
Topics: Amides; Aminosalicylic Acids; Anti-Ulcer Agents; Antipsychotic Agents; Bimatoprost; Cloprostenol; Cyclohexanes; Drug Approval; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Galantamine; Glaucoma; Gonadotropin-Releasing Hormone; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Lipids; Mesalamine; Nateglinide; Nootropic Agents; Phenylalanine; Phenylhydrazines; Piperazines; Thiazoles; Travoprost | 2002 |
Different embryo-fetal toxicity effects for three VLA-4 antagonists.
Topics: Abnormalities, Drug-Induced; Animals; Benzene Derivatives; Cell Communication; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Embryo, Mammalian; Embryonic Development; Female; Homozygote; Imidazoles; Integrin alpha4beta1; Maternal Exposure; Maternal-Fetal Exchange; Mice; Models, Chemical; Phenylalanine; Phenylurea Compounds; Pregnancy; Pregnancy, Animal; Propionates; Rabbits; Rats; Species Specificity; Teratogens | 2004 |
Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
Topics: Abnormalities, Drug-Induced; Animals; Aorta; Area Under Curve; Benzene Derivatives; Cell Adhesion; Cell Line; Chorion; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Embryo, Mammalian; Embryonic Development; Female; Heart; Humans; Imidazoles; Inhibitory Concentration 50; Integrin alpha4beta1; Maternal Exposure; Maternal-Fetal Exchange; Models, Chemical; Phenylalanine; Phenylurea Compounds; Pregnancy; Pregnancy, Animal; Propionates; Protein Binding; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Very Late Antigen; Species Specificity; Teratogens; Time Factors | 2004 |
Colon-specific mutual amide prodrugs of 4-aminosalicylic acid for their mitigating effect on experimental colitis in rats.
Topics: Aminosalicylic Acids; Animals; Colitis; Colon; Drug Delivery Systems; Drug Stability; Drug-Related Side Effects and Adverse Reactions; Liver; Pancreas; Prodrugs; Rats; Ulcer | 2009 |